Evolution-guided evaluation of the inverted terminal repeats of the synthetic transposon Sleeping Beauty.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
04 02 2019
Historique:
received: 29 08 2018
accepted: 18 12 2018
entrez: 6 2 2019
pubmed: 6 2 2019
medline: 14 8 2020
Statut: epublish

Résumé

Sleeping Beauty (SB) is a synthetic Tc1/mariner transposon that is widely used for genetic engineering in vertebrates, including humans. Its sequence was derived from a consensus of sequences found in fish species including the Atlantic salmon (Salmo salar). One of the functional components of SB, the transposase enzyme, has been subject to extensive mutagenesis yielding hyperactive protein variants for advanced applications. The second functional component, the transposon inverted terminal repeats (ITRs), has so far not been extensively modified, mainly due to a lack of natural sequence information. Importantly, as genome sequences become available, they can provide a rich source of information for a refined molecular definition of the functional components of these transposons. Here we have mined the Salmo salar genome for a comprehensive set of transposon sequences that were used to build a refined consensus sequence. We synthetically produced the new consensus ITR sequences and used them to build a new transposon, the performance of which has been tested in cell-based transposition assays. The consensus sequence did not support enhanced transposition, suggesting alternative mechanisms responsible for the preferential amplification of these sequence variants in the salmon genome.

Identifiants

pubmed: 30718656
doi: 10.1038/s41598-018-38061-w
pii: 10.1038/s41598-018-38061-w
pmc: PMC6362248
doi:

Substances chimiques

DNA Transposable Elements 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1171

Références

Trends Genet. 1999 Aug;15(8):326-32
pubmed: 10431195
Genome Res. 2002 Apr;12(4):656-64
pubmed: 11932250
J Mol Biol. 2002 May 17;318(5):1221-35
pubmed: 12083513
Nucleic Acids Res. 2002 Jul 15;30(14):3059-66
pubmed: 12136088
Syst Biol. 2003 Oct;52(5):696-704
pubmed: 14530136
Science. 2004 Mar 12;303(5664):1626-32
pubmed: 15016989
Mol Cell Biol. 2004 May;24(9):4004-18
pubmed: 15082793
Bioinformatics. 2009 May 1;25(9):1189-91
pubmed: 19151095
Nat Genet. 2009 Jun;41(6):753-61
pubmed: 19412179
Blood. 2009 Aug 20;114(8):1461-8
pubmed: 19471016
Nat Methods. 2009 Jun;6(6):415-22
pubmed: 19478801
Mol Biol Evol. 2010 Feb;27(2):221-4
pubmed: 19854763
Mol Ther. 2010 Apr;18(4):674-83
pubmed: 20104209
Bioessays. 2010 Sep;32(9):756-67
pubmed: 20652893
Genome Biol. 2010;11(9):403
pubmed: 20887641
Mob DNA. 2010 Dec 07;1(1):25
pubmed: 21138556
Mob DNA. 2013 May 15;4(1):15
pubmed: 23676100
Algorithms Mol Biol. 2014 Mar 06;9(1):4
pubmed: 24602402
Curr Gene Ther. 2015;15(3):255-65
pubmed: 25619886
Nucleic Acids Res. 2016 Jan 4;44(D1):D27-37
pubmed: 26615188
Nat Commun. 2016 Mar 30;7:11126
pubmed: 27025571
Nature. 2016 Apr 18;533(7602):200-5
pubmed: 27088604
Crit Rev Biochem Mol Biol. 2017 Aug;52(4):355-380
pubmed: 28402189
Hum Gene Ther. 2017 Nov;28(11):1087-1104
pubmed: 28920716
J Mol Evol. 1985;22(2):160-74
pubmed: 3934395
Proc Natl Acad Sci U S A. 1996 May 14;93(10):5008-13
pubmed: 8643520
Cell. 1997 Nov 14;91(4):501-10
pubmed: 9390559

Auteurs

Barbara Scheuermann (B)

Faculty of Biology, Johannes Gutenberg University of Mainz, 55128, Mainz, Germany.

Tanja Diem (T)

Division of Medical Biotechnology, Paul Ehrlich Institute, Langen, Germany.

Zoltán Ivics (Z)

Division of Medical Biotechnology, Paul Ehrlich Institute, Langen, Germany. Zoltan.Ivics@pei.de.

Miguel A Andrade-Navarro (MA)

Faculty of Biology, Johannes Gutenberg University of Mainz, 55128, Mainz, Germany. andrade@uni-mainz.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH